<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for DUSA Pharmaceuticals Inc - Google Finance</title>
<description>News for DUSA Pharmaceuticals Inc - Google Finance</description>
<link>http://www.google.com/finance?q=NASDAQ:DUSA&amp;amp;client=news-rss&amp;amp;ei=Z3GdUfDIIYW40gGBogE</link>
<image>
<title>News for DUSA Pharmaceuticals Inc - Google Finance</title>
<url>/finance/s/M4XFgDr56u4/images/logo_us.gif</url>
<link>http://www.google.com/finance?q=NASDAQ:DUSA&amp;amp;client=news-rss&amp;amp;ei=Z3GdUfDIIYW40gGBogE</link>
</image>
<item>
<title>WCUI&amp;#39;s Psoria-Shield(R) Announces Sales Roll-Out of Psoria-Light(R) to Key ...</title>
<link>http://www.spaceref.com/news/viewpr.html?pid=40846</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982069644581</guid>
<pubDate>Wed, 22 May 2013 17:12:01 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.spaceref.com/news/viewpr.html?pid=40846&quot; style=&quot;font-size:1.2em&quot;&gt;WCUI&amp;#39;s Psoria-Shield(R) Announces Sales Roll-Out of Psoria-Light(R) to Key ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Space Ref (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;8 hours ago &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;He has brought value to several major market players, including Lumenis, Ra Medical, and DUSA Pharmaceutical. Ra Medical ... Psoria-Shield Inc. designs, manufactures, and distributes medical devices under an ISO 13485 quality management system.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Celsus Therapeutics Strengthens Board of Directors With Addition of ...</title>
<link>http://www.marketwire.com/press-release/celsus-therapeutics-strengthens-board-directors-with-addition-dermatology-industry-veteran-otcqb-mrrby-1785022.htm</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778140396311</guid>
<pubDate>Wed, 01 May 2013 12:13:10 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.marketwire.com/press-release/celsus-therapeutics-strengthens-board-directors-with-addition-dermatology-industry-veteran-otcqb-mrrby-1785022.htm&quot; style=&quot;font-size:1.2em&quot;&gt;Celsus Therapeutics Strengthens Board of Directors With Addition of ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Marketwire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 1, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Most recently Bob served as President and Chief Executive Officer of DUSA Pharmaceuticals, Inc., a publicly traded specialty pharmaceutical and medical device company focused in the field of dermatology.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>SMaRT Therapeutics Announces Appointment of Dr. John H. Abeles to the ...</title>
<link>http://www.marketwatch.com/story/smart-therapeutics-announces-appointment-of-dr-john-h-abeles-to-the-advisory-board-2013-04-30</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778139343683</guid>
<pubDate>Tue, 30 Apr 2013 12:33:22 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.marketwatch.com/story/smart-therapeutics-announces-appointment-of-dr-john-h-abeles-to-the-advisory-board-2013-04-30&quot; style=&quot;font-size:1.2em&quot;&gt;SMaRT Therapeutics Announces Appointment of Dr. John H. Abeles to the ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;MarketWatch (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 30, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;I find the technology both fascinating and compelling as it could enable the company to avoid the obstacles that other RNA technologies like RNAi, antisense and microRNA have as of yet been unable to overcome.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Law Office of Brodsky &amp;amp; Smith, LLC Announces Investigation of DUSA Pharmaceuticals, Inc.</title>
<link>http://www.reuters.com/finance/stocks/DUSA.O^L12/key-developments/article/2642693</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:2642693</guid>
<pubDate>Wed, 14 Nov 2012 01:00:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/DUSA.O^L12/key-developments/article/2642693&quot; style=&quot;font-size:1.2em&quot;&gt;Law Office of Brodsky &amp;amp; Smith, LLC Announces Investigation of DUSA Pharmaceuticals, Inc.&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Nov 14, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Law Office of Brodsky &amp;amp; Smith, LLC Announces Investigation Of Dusa Pharmaceuticals Inc</title>
<link>http://www.reuters.com/finance/stocks/DUSA.O^L12/key-developments/article/2641478</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:2641478</guid>
<pubDate>Sat, 10 Nov 2012 16:00:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/DUSA.O^L12/key-developments/article/2641478&quot; style=&quot;font-size:1.2em&quot;&gt;Law Office of Brodsky &amp;amp; Smith, LLC Announces Investigation Of Dusa Pharmaceuticals Inc&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Nov 10, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>WeissLaw LLP Investigates Dusa Pharmaceuticals Inc</title>
<link>http://www.reuters.com/finance/stocks/DUSA.O^L12/key-developments/article/2640947</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:2640947</guid>
<pubDate>Fri, 09 Nov 2012 23:25:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/DUSA.O^L12/key-developments/article/2640947&quot; style=&quot;font-size:1.2em&quot;&gt;WeissLaw LLP Investigates Dusa Pharmaceuticals Inc&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Nov 9, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Faruqi &amp;amp; Faruqi, LLP Seeking More Cash For Shareholders Of Dusa Pharmaceuticals Inc</title>
<link>http://www.reuters.com/finance/stocks/DUSA.O^L12/key-developments/article/2640012</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:2640012</guid>
<pubDate>Fri, 09 Nov 2012 00:01:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/DUSA.O^L12/key-developments/article/2640012&quot; style=&quot;font-size:1.2em&quot;&gt;Faruqi &amp;amp; Faruqi, LLP Seeking More Cash For Shareholders Of Dusa Pharmaceuticals Inc&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Nov 9, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Dusa Pharmaceuticals Inc</title>
<link>http://www.reuters.com/finance/stocks/DUSA.O^L12/key-developments/article/2639919</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:2639919</guid>
<pubDate>Thu, 08 Nov 2012 21:04:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/DUSA.O^L12/key-developments/article/2639919&quot; style=&quot;font-size:1.2em&quot;&gt;Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Dusa Pharmaceuticals Inc&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Nov 8, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Dusa Pharmaceuticals Inc&amp;#39;s Board of Directors Under Investigation For Potential Breaches Of Fiduciary Duty By Glancy Binkow &amp;amp; Goldberg LLP</title>
<link>http://www.reuters.com/finance/stocks/DUSA.O^L12/key-developments/article/2639828</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:2639828</guid>
<pubDate>Thu, 08 Nov 2012 18:29:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/DUSA.O^L12/key-developments/article/2639828&quot; style=&quot;font-size:1.2em&quot;&gt;Dusa Pharmaceuticals Inc&amp;#39;s Board of Directors Under Investigation For Potential Breaches Of Fiduciary Duty By Glancy Binkow &amp;amp; Goldberg LLP&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Nov 8, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Harwood Feffer LLP Announces Investigation of Dusa Pharmaceuticals Inc</title>
<link>http://www.reuters.com/finance/stocks/DUSA.O^L12/key-developments/article/2639810</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:2639810</guid>
<pubDate>Thu, 08 Nov 2012 17:57:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/DUSA.O^L12/key-developments/article/2639810&quot; style=&quot;font-size:1.2em&quot;&gt;Harwood Feffer LLP Announces Investigation of Dusa Pharmaceuticals Inc&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Nov 8, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
